Latanoprost Polpharma

Latanoprost, the active ingredient in Latanoprost Polpharma, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is employed in the management of glaucoma and ocular hypertension in adult patients.

GNH USA supplies Latanoprost Polpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across multiple regions. Customers benefit from reliable logistics and responsive technical support throughout the supply chain.

Latanoprost is a prostaglandin analog used to reduce intra‑ocular pressure in glaucoma‑related conditions.

- Open-angle glaucoma: lowers intra‑ocular pressure to prevent optic nerve damage. - Ocular hypertension: reduces elevated eye pressure to lower risk of progression to glaucoma. - Secondary open-angle glaucoma: helps control pressure when caused by other ocular diseases.

Latanoprost may cause ocular and systemic reactions, most of which are mild and reversible.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris darkening: gradual pigmentation change. - Eye irritation: transient burning or stinging. - Blurred vision: temporary visual disturbance. - Periorbital skin darkening: mild hyperpigmentation.

Serious or Rare Side Effects: - Severe eye inflammation: uveitis or iritis requiring medical attention. - Allergic reaction: swelling, itching, or rash around the eye. - Vision changes: sudden loss of vision or visual field defects. - Ocular infection: signs of bacterial or fungal infection. - Corneal edema: swelling of the cornea affecting clarity.

Before initiating Latanoprost therapy, consider the following safety measures.

- Monitor intra‑ocular pressure: ensure adequate reduction and avoid hypotony. - Assess for ocular infection: do not use if active eye infection is present. - Avoid contact lens use initially: lenses may absorb the medication and cause irritation. - Inform ophthalmologist of upcoming eye surgery: discontinue before procedures as advised. - Store at room temperature: keep in original container, protect from light and moisture.

Latanoprost can interact with other ocular or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid): - Concurrent use with other prostaglandin analog eye drops: may cause excessive ocular irritation. - Combination with systemic beta‑blockers: additive intra‑ocular pressure lowering may lead to hypotony.

Moderate Interactions (Monitor Closely): - Use with topical corticosteroids: may reduce Latanoprost's IOP‑lowering effect. - Use with contact lenses: may cause drug deposits and discomfort. - Concomitant systemic NSAIDs: potential slight reduction in therapeutic response.